Contact Us

Sibelius News, Events & Articles

9 December 2010 
RDC5 Reduces the Levels of Toxic Protein Aggregates
In pre-clinical models, Chronos Therapeutics' patented compound RDC5 and CHR1 (originally identified via the Chronoscreen™)show significant effects on pre-clinical model […]
1 October 2010 
Completion of the 30,000 compound analysis in Chronoscreen™ Initiated in February 2010
28 September 2010 
Cold Spring Harbor Molecular Genetics of Aging Conference
New York 28th Sept - 2nd Oct 2010
15 July 2010 
British Royal Society on Aging Meeting
Newcastle upon Tyne 15th - 16th July 2010
Load more
Subscribe to Our Newsletter
Keep up to date with the latest insights
news, events, developments and
product launches
Newsletter Subscribe

How can we help you?

Please fill in the form below and a member of the team will get back to you. To read our privacy policy, click here.
How can we help?